Connecting haematologists worldwide
through mentorship and lifelong learning
UPCOMING ESH CONFERENCES
ESH plenary conference programmes are designed to place emphasis on leading-edge
basic and clinical research and future perspectives. Ample time is deliberately provided
for in-depth scientific discussion and interaction. Registered participants further benefit
from a variety of opportunities for informal scientific interaction with the world’s leading
experts in their field, including during small Meet the Expert sessions and Mentored
Posters Walks. ESH conference delegates are invited to submit abstracts. Selected
abstracts are presented as brief oral communications or posters.
2021 – 1st SEMESTER
2021 – 2nd SEMESTER
info@esh.org - www.esh.org
Folowus on twiter@ESHaematology
SCIENTIFIC PROGRAMME
SESSION I
OPTIMIZING
CYTOREDUCTION
SESSION II
MANAGEMENT OF CML
WITH TKI
SESSION III
MPN RISK
STRATIFICATION
INCLUDING VASCULAR
EVENTS
DEBATE 1
INTERFERON ALPHA
SHOULD BE FRONT LINE
THERAPY IN ALL ET/PV
PATIENTS
ROUNDTABLE 1
INFECTIONS IN
MYELOPROLIFERATIVE
DISORDERS, INCLUDING
CML
ROUNDTABLE 2
PREGNANCY AND
PARENTING
DEBATE 2
ALLOGENEIC STEM CELL
TRANSPLANTATION
SHOULD BE CONSIDERED
THIRD LINE OPTION IN
CHRONIC PHASE CML
SESSION IV
EVOLVING THERAPIES
IN MYELOFIBROSIS
SESSION V
MANAGEMENT OF
ADVANCED AND UNUSUAL
DISEASE (MPN AND CML)
SESSION VI
TREATMENT FREE
REMISSION IN CML
KEYNOTE LECTURE
SELECTED ABSTRACTS
FOR AN ORAL
PRESENTATION
SELECTED ABSTRACTS
FO R A POSTER
PRESENTATION
DISCLOSURES